By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm IncellDx today said it has closed a $3 million Series A financing.

IncellDx did not disclose the names of the investors in the round.

Proceeds will be used to further commercialize the company's products and initiate the US clinical trial for its test for human papillomavirus, HPV OncoTect, a CE-marked E6, E7 mRNA test, IncellDx said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.